Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: David Culver who wrote (1124)	12/2/1998 10:11:00 PM
From: Chuca Marsh	Respond to of 1501

I'll trade you one Phase 3 for your Phase 1. Not to kid about the Cancer Compound, it is not the Inflazyme one but interesting for further thought:<<..** Press Release, Wednesday December 2, 8:00am: AVI BioPharma Inc. Announces Phase II Clinical Results of Lead Cancer Therapeutic, Avicine, In Pancreatic Cancer. SuperGen Drug in Phase III. biz.yahoo.com ..>> Chuca

To: David Culver who wrote (1124)	12/22/1998 4:02:00 PM
From: Harold Lehman	Read Replies (2) \| Respond to of 1501

I spoke with Mr McBeath earlier today and asked about the status of the 14-day animal dosing studies. This will be completed by the end of the first week of January, and then the data (histopathology) will be analyzed. This involves three different pathologists independently analyzing the slides and then arriving at a conclusion that all of them agree upon. The completion date for data analysis should be sometime in March, and if everything goes well the data can be submitted for initiation of Phase 1 human studies. In animal studies to date, so far no toxic effects have been seen. I'm hoping that the new year will bring not just an end to tax-loss selling, but a revival of interest in small-cap stocks, esp. biotechs. It's possible. If you've heard a lot of analysts in the last few months many of them are talking about the compelling values many small stocks offer, but wonder what the catalyst will be to ignite this sector. Happy holidays everyone. Harold